Skip to main content

Advertisement

Log in

Expression of extracellular matrix-proteins in perisellar connective tissue and dura mater

  • Experimental Research
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Purpose

To describe the pattern of expression of extracellular matrix (ECM) proteins in perisellar connective tissue.

Methods

Dural and perisellar specimens from ten individuals were investigated immunohistochemically for collagens I to IV, tenascin, fibronectin, elastin, laminin, and vitronectin.

Findings

Collagen I and III and fibronectin were strongly expressed and collagen IV, tenascin, and vitronectin were moderately expressed in the boundaries of the sella and around the CS. In six of nine specimens from the anterior boundary of the sella, and in 11 of 19 samples from the lateral boundary of the sella (medial wall of CS), two different layers could be detected by the expression of different ECM proteins. None of the antigens generally allowed differentiation between two layers of the pituitary envelope.

Conclusions

The pituitary boundary may consist of a single or a double layer, infrequently differentiated from each other by the expression of different ECM proteins.

Summary

Background

The medial wall (MW) of the cavernous sinus (CS) was described as fragile with small defects allowing pituitary adenomas to penetrate it, whereas other publications focus on biological properties of pituitary adenomas leading to cavernous sinus infiltration. Against this background, we describe the pattern of expression of extracellular matrix (ECM) proteins in perisellar connective tissue as possible targets for tumor-derived proteinases.

Methods

Post-mortem specimens were obtained from ten individuals without endocrinological disorders: diaphragma sellae, anterior and lateral wall of pituitary boundary (MW of CS), lateral wall of CS, convexity dura, tentorial dura, temporal fascia, intracavernous internal carotid artery (ICA), and internal jugular vein. Immunohistochemical detection of collagens I to IV, tenascin, fibronectin, elastin, laminin, and vitronectin was performed.

Findings

Collagens I and III were strongly expressed and collagen II weakly expressed, and collagen IV moderately expressed in the lateral as well as anterior boundaries of the sella and around the CS. Fibronectin was strongly expressed, tenascin and vitronectin were moderately expressed in the edge of the sellar compartment and dura mater, whereas expression of elastin and laminin was weak or absent. In six of nine specimens derived from the anterior boundary of the sella, and in 11 of 19 samples obtained from the lateral boundary of the sella (MW of CS), two different layers could be detected by the expression of different ECM proteins. None of the antigens investigated generally allowed differentiation between two layers of the pituitary covering.

Conclusions

The pituitary boundary may consist of a single or a double layer. Infrequently the pituitary capsule can be differentiated from dura mater concerning the expression of different ECM proteins. The combination of individual anatomy and pattern of ECM expression in a given case, and biological properties of the adenoma may be important for the occurrence of CS infiltration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Beier UH, Holtmeier C, Weise JB, Gorogh T (2007) Fibronectin suppression in head and neck cancers, inflammatory tissues and the molecular mechanisms potentially involved. Int J Oncol 30:621–629

    CAS  PubMed  Google Scholar 

  2. Campero A, Martins C, Yasuda A, Rhoton AL Jr (2008) Microsurgical anatomy of the diaphragma sellae and its role in directing the pattern of growth of pituitary adenomas. Neurosurgery 62:717–723

    Article  PubMed  Google Scholar 

  3. Destrieux C, Kakou MK, Velut S, Lefrancq T, Jan M (1998) Microanatomy of the hypophyseal fossa boundaries. J Neurosurg 88:743–752

    Article  CAS  PubMed  Google Scholar 

  4. Dietemann JL, Kehrli P, Maillot C, Diniz R, Reis M Jr, Neugroschl C, Vinclair L (1998) Is there a dural wall between the cavernous sinus and the pituitary fossa? anatomical and MRI findings. Neuroradiology 40:627–630

    Article  CAS  PubMed  Google Scholar 

  5. Dreiling FJ, Henson MM, Henson OW (2002) Immunolabeling type II collagen in the basilar membrane, a pre-embedding approach. Hear Res 166:181–191

    Article  CAS  PubMed  Google Scholar 

  6. Farnoud MR, Kujas M, Derome P, Racadot J, Peillon F, Li JY (1994) Interactions between normal and tumoral tissues at the boundary of human anterior pituitary adenomas. An immunohistochemical study. Virchows Arch 424:75–82

    Article  CAS  PubMed  Google Scholar 

  7. Felix A, Rosa JC, Fonseca I, Cidadao A, Soares J (2004) Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy. Histopathology 45:187–192

    Article  CAS  PubMed  Google Scholar 

  8. Garibi J, Pomposo I, Villar G, Gaztambide S (2002) Giant pituitary adenomas: clinical characteristics and surgical results. Br J Neurosurg 16:133–139

    Article  CAS  PubMed  Google Scholar 

  9. Honegger J, Prettin C, Feuerhake F, Petrick M, Schulte-Mönting J, Reincke M (2003) Expression of Ki-67 antigen in non-functioning pituitary adenomas: correlation with growth velocity and invasiveness. J Neurosurg 99:674–679

    Article  PubMed  Google Scholar 

  10. Horton WA, Dwyer C, Goering R (1983) Immunohistochemistry of types I and II collagen in undecalcified skeletal tissues. J Histochem Cytochem 31:417–425

    CAS  PubMed  Google Scholar 

  11. Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi CU, Redpath GT, Fang Z, Leung GK, Lopes MB, Laws ER (2007) Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and non-invasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170:356–365

    Article  CAS  PubMed  Google Scholar 

  12. Ikeda H, Yoshimoto T, Fujiwara K, Ogawa Y (1995) Immunohistochemical demonstration of tenascin in human pituitary glands and adenomas. Acta histochem (Jena) 97:273–280

    CAS  Google Scholar 

  13. Kawamoto H, Uozumi T, Kawamoto K, Arita K, Yano Y, Hirohata T (1996) Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas. Acta Neurochir (Wien) 138:390–395

    Article  CAS  Google Scholar 

  14. Knappe UJ, Luedecke DK (1996) Transnasal microsurgery in children and adolescents with Cushing`s disease. Neurosurgery 39:484–493

    Article  CAS  PubMed  Google Scholar 

  15. Knappe UJ, Hagel C, Lisboa BW, Wilczak W, Luedecke DK, Saeger W (2003) Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue. Acta Neuropathol 106:471–478

    Article  CAS  PubMed  Google Scholar 

  16. Knappe UJ, Konerding MA, Schoenmayr R (2009) Medial wall of the cavernous sinus: microanatomical diaphanoscopic and episcopic investigation. Acta Neurochir (Wien) 151:961–967

    Article  Google Scholar 

  17. Knappe UJ, Jaursch-Hancke C, Schoenmayr R, Loercher U (2009) Assessment of normal perisellar anatomy in 1.5 T T2-weighted MRI and comparison with the anatomical criteria defining cavernous sinus invasion of pituitary adenomas. Cent Eur Neurosurg 70:130–136

    Article  CAS  Google Scholar 

  18. Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of cavernous space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617

    Article  CAS  PubMed  Google Scholar 

  19. Kumagai J, Sarkar K, Uhthoff HK, Okawara Y, Ooshima A (1994) Immunohistochemical distribution of type I, II and III collagens in the rabbit supraspinatus tendon insertion. J Anat 185:279–284

    CAS  PubMed  Google Scholar 

  20. Kursat E, Yilmazlar S, Aker S, Aksoy K, Oygucu H (2008) Comparison of lateral and superior walls of the pituitary fossa with clinical emphasis on pituitary adenoma extension: cadaveric-anatomic study. Neurosurg Rev 31:91–99

    Article  PubMed  Google Scholar 

  21. Liu W, Kunishio K, Matsumoto Y, Okada M, Nagao S (2005) Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas. J Clin Neurosci 12:791–794

    Article  CAS  PubMed  Google Scholar 

  22. Losa M, Mortini P, Barzaghi R, Ribotto P, Terreni MR, Marzoli SB, Pieralli S, Giovanelli M (2008) Early results of surgery in patients with non-functioning pituitary adenomas and analysis of the risk of tumor recurrence. J Neurosurg 108:525–532

    Article  PubMed  Google Scholar 

  23. Mastronardi L, Guidicci A, Spera C, Puzzilli F, Liberati F, Maira G (1999) Ki-67 labelling index and invasiveness among pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol 52:107–111

    Article  CAS  PubMed  Google Scholar 

  24. Paez-Pereda M, Kuchenbauer F, Arzt E, Stalla GK (2005) Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix. Braz J Med Biol Res 38:1487–1494

    Article  CAS  PubMed  Google Scholar 

  25. Pamir MN, Kilic T, Ozek MM, Ozduman K, Ture U (2006) Non-meningeal tumours of the cavernous sinus: a surgical analysis. J Clin Neurosci 13:626–635

    Article  PubMed  Google Scholar 

  26. Peker S, Kurtkaya-Yapicier O, Kilic T, Pamir MN (2005) Microsurgical anatomy of the lateral walls of the pituitary fossa. Acta Neurochir (Wien) 147:641–649

    Article  CAS  Google Scholar 

  27. Qian ZR, Sano T, Yoshimoto K, Asa SL, Yamada S, Mizusawa N, Kudo E (2007) Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Mod Pathol 20:1269–1277

    Article  CAS  PubMed  Google Scholar 

  28. Saeger W, Luedecke B, Luedecke DK (2008) Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas. Exp Clin Endocrinol Diabetes 116:80–85

    Article  CAS  PubMed  Google Scholar 

  29. Scheithauer BW, Kurtkaya-Yapicier O, Kovacs KT, Young WF Jr, Lloyd RV (2005) Pituitary carcinoma: a clinicopathological review. Neurosurgery 56:1066–1074

    PubMed  Google Scholar 

  30. Songtao Q, Yuntao L, Jun P, Chuanping H, Xiaofeng S (2009) Membraneous layers of the pituitary gland: histological anatomical study and related clinical issues. Neurosurgery 64(ONS Suppl 1):ons1–ons10

    Article  Google Scholar 

  31. Thapar K, Kovacs KT, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER Jr (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99–107

    Article  CAS  PubMed  Google Scholar 

  32. Trouillas J, Daniel L, Guigard M-P, Tong S, Gouvernet J, Jouanneau E, Jan M, Perrin G, Fischer G, Tabarin A, Rougon G, Figarella-Branger D (2003) Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion. J Neurosurg 98:1084–1093

    Article  CAS  PubMed  Google Scholar 

  33. Wei Y, Tang CH, Kim Y, Robillard L, Zhang F, Kugler MC, Chapman HA (2007) Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signalling in tumor cells. J Biol Chem 282:3929–3939

    Article  CAS  PubMed  Google Scholar 

  34. Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K, Takano K, Sano T (2007) A study of the correlation between morphological findings and biological activities in clinically non-functioning adenomas. Neurosurgery 61:580–584

    Article  PubMed  Google Scholar 

  35. Yasuda A, Campero A, Martins C, Rhoton AL Jr, Ribas GC (2004) The medial wall of the cavernous sinus: microsurgical anatomy. Neurosurgery 55:179–190

    Article  PubMed  Google Scholar 

  36. Yilmazlar S, Kocaeli H, Aydiner F, Korfali E (2005) Medial portion of the cavernous sinus: quantitative analysis of the medial wall. Clin Anat 18:416–422

    Article  PubMed  Google Scholar 

  37. Yokoyama S, Hirano H, Moroki K, Goto M, Imamura S, Kuratsu J-I (2001) Are nonfuntioning adenomas extending into the cavernous sinus aggressive and/or invasive? Neurosurgery 49:857–863

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors appreciated the excellent help of Mrs. D. Clauss and Mrs. Z.I. Apostolou-Keiper for preparation of the immunohistological slides.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ulrich J. Knappe.

Additional information

Comment

The authors present a cadaveric study of the extracellular matrix proteins in the perisellar area. The study indicates that the ECM at junction of the pituitary and the medial wall of the cavernous sinus is highly variable. Cavernous sinus invasion by pituitary adenomas may not simply relate to biological nature of the adenoma itself but also to anatomical differences between patients whose pituitary capsule and medial cavernous sinus walls may be more susceptible to penetration.

John Jane, Jr. M.D.,

Charlottesville, USA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knappe, U.J., Fink, T., Fisseler-Eckhoff, A. et al. Expression of extracellular matrix-proteins in perisellar connective tissue and dura mater. Acta Neurochir 152, 345–353 (2010). https://doi.org/10.1007/s00701-009-0497-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-009-0497-9

Keywords

Navigation